Press Releases

Date Title and Summary
Toggle Summary Capnia Acquires Neonatal Pulmonary Resuscitation Solutions From NeoForce Group, Inc.
Acquisition Strengthens Capnia's Presence in Neonatology NeoForce President and Chief Executive Officer to Join Capnia as General Manager of Neonatology REDWOOD CITY, Calif. , Sept. 8, 2015 (GLOBE NEWSWIRE) -- Capnia, Inc. (NASDAQ:CAPN), focused on the development and commercialization of novel
Toggle Summary Capnia Added to Russell Microcap(R) Index
REDWOOD CITY, Calif. , June 29, 2015 (GLOBE NEWSWIRE) -- Capnia, Inc. (Nasdaq:CAPN), focused on the development of novel products based on its proprietary technologies for precision metering of gas flow, today announced it was added to the Russell Microcap® Index when the Russell Investment Group
Toggle Summary Capnia and Clinvest® Partner to Develop Cluster Headache Therapeutic
REDWOOD CITY, Calif. , Jan. 6, 2015 / PRNewswire / -- Capnia, Inc. (NASDAQ: CAPN), focused on the development of novel diagnostics and therapeutics based on its proprietary technologies for precision metering of gas flow, and Clinvest®, a research organization dedicated to the advancement of
Toggle Summary Capnia and Essentialis Announce Merger to Create Rare Disease Therapeutics Company
Combined Company to Focus on Advancing Novel, Late-Stage Asset for the Treatment of Prader-Willi Syndrome, a Devastating, Orphan Disease  Enrollment in a Phase II/III Clinical Trial Expected to Begin in Second Half of 2017 $8 Million Concurrent Financing; Sufficient to Fund Development Plan Through
Toggle Summary Capnia Announces $10 Million At-the-Market Firm Commitment Stock Purchase Agreement With Aspire Capital
Company Advancing Promising Treatment for Cluster Headache, Trigeminal Neuralgia and Allergic Rhinitis REDWOOD CITY, Calif. , July 27, 2015 (GLOBE NEWSWIRE) -- Capnia, Inc. (NASDAQ:CAPN), focused on the development and commercialization of novel products based on its proprietary technologies for
Toggle Summary Capnia Announces Commencement of Series B Warrant Exchange Offer
REDWOOD CITY, Calif. , June 26, 2015 (GLOBE NEWSWIRE) -- Capnia, Inc. (Nasdaq:CAPN), focused on the development of novel products based on its proprietary technologies for precision metering of gas flow, today announced that its previously filed Registration Statement on Form S-4 in connection with
Toggle Summary Capnia Announces Enrollment of First Patient in Clinical Trial for Treatment of Cluster Headache
REDWOOD CITY, Calif. , July 22, 2015 (GLOBE NEWSWIRE) -- Capnia, Inc. (NASDAQ:CAPN), focused on the development and commercialization of novel products based on its proprietary technologies for precision metering of gas flow, today announced enrollment of the first patient in an
Toggle Summary Capnia Announces Exclusive Distribution Agreement for CoSense® End-Tidal Carbon Monoxide Monitor in India
-Agreement represents continued expansion of CoSense outside the US- REDWOOD CITY, Calif. , June 07, 2016 (GLOBE NEWSWIRE) -- Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops and commercializes innovative diagnostics, devices and therapeutics addressing unmet medical
Toggle Summary Capnia Announces Exclusive Distribution Agreement for Sale of CoSense® in China
Five-year agreement represents significant expansion of CoSense outside the US REDWOOD CITY, Calif. , March 16, 2016 (GLOBE NEWSWIRE) -- Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops and commercializes innovative diagnostics, devices and therapeutics addressing unmet
Toggle Summary Capnia Announces Expiration of Series B Warrants
REDWOOD CITY, Calif. and PALO ALTO, Calif. , Feb. 16, 2016 (GLOBE NEWSWIRE) -- Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops innovative diagnostics, devices and therapeutics addressing unmet medical needs, announced the expiration of the Company’s Series B Warrants as
Print Page RSS Feeds Email Alerts IR Contacts